Poultry products such as meat, chicken, eggs, and others are widely consumed globally. Demand for these products is on the rise, moreover, increasing demand for animal-based protein is a major factor, which is expected to drive growth of the poultry pharmaceuticals market over the forecast period. The increasing poultry population and the growing prevalence of avian diseases are anticipated to enhance the demand for poultry vaccines. There is a surge in demand for poultry vaccines because of the increasing number of zoonotic cases. Poultry vaccine helps prevent a specific disease by considerably accelerating their immune system to develop antibodies to battle against the invading organisms. Poultry vaccines play a major role in poultry disease control and prevention. The majority of poultry-killed vaccines are developed to fight against viral diseases. These vaccines are administered in different forms, such as nasal, oral, ocular, vivo, subcutaneous, and intramuscular.

Market Dynamics

Key market players are focusing on launch of new vaccine to protect poutry against Marek's Disease is expected to the global inactivated poultry pharmaceuticals market growth over the forecast period. For instance, in 2020, Boehringer Ingelheim, a research-driven group of companies dedicated to the discovery, development, manufacture and marketing of innovative health care products in Germany, launched the VAXXITEK HVT+IBD+ND vaccine to protect poultry against Marek's Disease, Newcastle Disease, and Infectious Bursal Disease (classic and variant types). Boehringer Ingelheim will produce VAXXITEK HVT+IBD+ND from its site which develops more than 60 billion doses of poultry vaccine a year for use in the U.S. and over 60 other countries.

Key features of the study:

• This report provides an in-depth analysis of the global poultry pharmaceuticals market and provides market size (US$ Billion) and compound annual growth rate (CAGR) for the forecast period (2023–2030), considering 2022 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global poultry pharmaceuticals market based on the following parameters– Company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Bayer AG, Bimeda, Ceva Sante Animale, Elanco Animal Health (Eli Lilly and Company), Merck Animal Health, Merial Animal Health (Sanofi), Virbac, Boehringer Ingelheim, Zoetis, Inc., Pacific GeneTech, and Avivagen Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global poultry pharmaceuticals market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global poultry pharmaceuticals market.

Detailed Segmentation:

• Global Poultry Pharmaceuticals Market, By Product Type:
  • Drugs
    • VETRIMOXIN
    • Other Drug Products
  • Vaccines
    • INNOVAX
    • NOBILIS
    • Poulvac
    • Other Vaccine Products
  • Feed Additives
    • VIGOSINE
    • Amnovit
    • Other Feed Additives
• Global Poultry Pharmaceuticals Market, By Animal Type :
  • Chicken
  • Turkey
  • Duck
  • Goose
  • Others
• Global Poultry Pharmaceuticals Market, By Region:
  • North America
    • By Country:
      • U.S.
      • Canada
  • Latin America
    • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • By Country:
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • By Country
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • By Country:
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • By Country/Region:
      • South Africa
      • Central Africa
      • North Africa
• Company Profiles
  • Bayer AG
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Bimeda
  • Ceva Sante Animale
  • Elanco Animal Health (Eli Lilly and Company)
  • Merck Animal Health
  • Merial Animal Health (Sanofi)
  • Virbac
  • Boehringer Ingelheim
  • Zoetis, Inc.
  • Pacific GeneTech
  • Avivagen Inc.

 “*” marked represents similar segmentation in other categories in the respective section.